The first vaccine to be used en masse against COVID-19 will have to contend with D614G, the latest mutation of SARS-CoV-2 Studies reveal D614G as the new dominant starin of SARS-CoV-2, the virus that ...

A localized resurgence of coronavirus infections across the United Kingdom—predominantly concentrated in London—has renewed ...

Just when it felt like COVID had quietly slipped into the background of everyday life, a new variant is back in the headlines. Reports suggest this strain carries multiple spike protein mutations and ...

(Reuters) - A specific mutation in the new coronavirus can significantly increase its ability to infect cells, according to a study by U.S. researchers. The research may explain why early outbreaks in ...

No, it's not a virus covered in stars and stripes.

The resurgence of Covid-19 cases observed in recent weeks is in line with the waves the virus causes every year and, ...

A new study provides early evidence that a Covid-19 vaccine might be effective against two new coronavirus strains first identified in South Africa and the UK, despite a concerning mutation. The two ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The LB.1 strain is trailing close behind FLuQE and FLiRT as the dominant variant in the country right now, and steadily ...

AUSTIN (KXAN) — Pharmaceutical companies are working to understand how effective COVID-19 vaccines are on variants being discovered worldwide — some that have already landed in the United States.

When researchers in China first discovered a new coronavirus spreading amongst the people in the city of Wuhan, they collected samples of the virus and published its genetic code online. Within weeks, ...